PI3K/mTOR dual kinase inhibitor XL765 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and g
For research use only. We do not sell to patients.
| Name | Voxtalisib ( XL-765) |
|---|---|
| Iupac Chemical Name | 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one |
| Synonyms | XL765; XL 765; XL-765; SAR245409; SAR245409; SAR 245409; Voxtalisib. |
| Molecular Formula | C13H14N6O |
| Molecular Weight | 270.29 |
| Smile | NC=1N=C(C2=C(N1)N(C(C(=C2)C2=NNC=C2)=O)CC)C |
| InChiKey | RGHYDLZMTYDBDT-UHFFFAOYSA-N |
| InChi | InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17) |
| CAS Number | 934493-76-2 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | white solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ℃ for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |